Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
COLL

Market Cap: $737.87M

CI

Collegium Pharmaceutical, Inc.

COLL

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin60.02%

EBITDA Margin72.58%

EBIT Margin29.65%

Pre-tax Margin9.61%

Net Profit Margin5.93%

Earnings Yield6.49%

Valuation Multiples

Price / Book2.37

Price / Sales0.91

Price / Earnings14.87

PEG0.50

Forward PEG-1.45

EV / Sales1.81

EV / EBITDA2.50

EV / Operating Cash Flow4.44

EV / Free Cash Flow4.47

Price / Free Cash Flow2.25

Price / Operating Cash Flow2.24

Cash Flow & Capital

Free Cash Flow / Share$10.11

Operating Cash Flow / Share$10.16

Free Cash Flow Yield44.49%

Capex / Revenue0.20%

Capex / Operating Cash Flow0.50%

Capex / Depreciation0.01

Stock Compensation / Revenue5.56%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.03

Quick Ratio0.84

Cash Ratio0.22

Debt / Assets0.40

Debt / Capital0.73

Debt / Equity2.75

Long-Term Debt / Capital0.72

Debt / Market Cap1.16%

Net Debt / EBITDA1.24

Solvency Ratio0.22

Financial Leverage6.85

Efficiency & Working Capital

Asset Turnover0.38

Fixed Asset Turnover55.95

Inventory Turnover2.85

Receivables Turnover2.83

Payables Turnover34.97

Days Sales Outstanding128.76

Days Inventory Outstanding127.95

Days Payables Outstanding10.44

Operating Cycle256.71

Cash Conversion Cycle246.27

Working Capital Turnover4.92

Returns & Quality

Return on Equity15.96%

Return on Assets2.24%

Return on Invested Capital6.10%

ROCE10.25%

Return on Tangible Assets6.31%

Operating Return on Assets8.37%

Income Quality6.89

Tax Burden0.62

Interest Burden0.32

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.47B

Invested Capital$1.41B

Working Capital$18.15M

Tangible Asset Value$-1.06B

Net Current Asset Value$-1.22B

Graham Number$17.86

Graham Net-Net-$43.87

Book Value / Share$9.61

Tangible Book Value / Share-$32.79

Cash / Share$3.99

Financial Health Scores

Piotroski Score5

Altman Z-Score0.94

Revenue$808.21M

EBIT$239.62M

Market Cap$743.38M

Working Capital$18.15M

Retained Earnings$-101.68M

Total Assets$2.14B

Total Liabilities$1.82B